Patents by Inventor Francesc Yraola Font

Francesc Yraola Font has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compounds for Inhibiting Copper-Containing Amine Oxidases and Uses Thereof
    Publication number: 20080269282
    Abstract: This invention is directed to inhibitors of copper-containing amine oxidases (E.C.1.4.3.6) including semicarbazide-sensitive amine oxidase (SSAO; also known as vascular adhesion protein-1, VAP-I), and their therapeutic use in inflammatory diseases, diabetes and its associated complications, atherosclerosis, neurodegenerative diseases, obesity, hypertension and cancer.
    Type: Application
    Filed: August 2, 2005
    Publication date: October 30, 2008
    Applicant: GENMEDICA THERAPEUTICS SL
    Inventors: Luc Marti Clauzel, Silvia Garcia Vicente, Francesc Yraola Font, Miriam Royo Exposito, Fernando Albericio Palomera, Antonio Zorzano Olarte
  • Arylalkylamine Vanadium (V) Salts for the Treatment and/or Prevention of Diabetes Mellitus
    Publication number: 20080227809
    Abstract: This invention provides compounds and pharmaceutical compositions thereof for treating human type 1 and type 2 diabetes, particularly insulin-resistant diabetes.
    Type: Application
    Filed: July 1, 2005
    Publication date: September 18, 2008
    Applicants: GENMEDICA THERAPEUTICS SL, UNIVERSIDAD DE BARCELONA
    Inventors: Miriam Royo Exposito, Luc Marti Clauzel, Anna Abella Marti, Silvia Garcia Vicente, Xavier Testar Ymbert, Antonio Zorzano Olarte, Manuel Palacin Prieto, Fernando Albericio Palomera, Francesc Yraola Font, Alec Mian
  • META-XYLYLENEDIAMINE VANADATE SALTS
    Publication number: 20080070987
    Abstract: The invention provides compounds of Formula (I): and Formula (II) or a pharmaceutically-acceptable salt, solvate, or hydrate thereof. Compounds of this invention, or pharmaceutical compositions thereof, are useful for treating diabetes, elevated plasma glucose levels, and/or ketoacidosis in mammals.
    Type: Application
    Filed: May 14, 2007
    Publication date: March 20, 2008
    Inventors: Francesc Yraola Font, Silvia Garcia Vicente, Juan Fernandez Recio, Fernando Albericio Palomera, Antonio Zorzano Olarte, Miriam Royo Exposito, Luc Marti Clauzel